Why the study?
Does intravenous verapamil improve or convert various cardiac arrhythmias in affected patients?
Does intravenous verapamil improve or convert various cardiac arrhythmias in affected patients?
Intravenous verapamil is highly effective and safe for the immediate management of various cardiac arrhythmias, particularly for converting paroxysmal supraventricular tachycardia to sinus rhythm and controlling ventricular rate in atrial fibrillation.
Answers are grounded in this paper and cite their sources.
May support acute arrhythmia management in select cases; hypothesis-generating and requires RCTs before practice change.
Verapamil was administered by intravenous injection to 181 patients with various cardiac arrhythmias. The automaticity of the cardiac pacemaker was slowed in sinus, idionodal, and idioventricular tachycardia. In atrial fibrillation the drug usually slowed the ventricular response and often made it regular. In some cases atrial flutter was converted to sinus rhythm, the ventricular response being reduced in the remainder. Conversion of paroxysmal supraventricular tachycardia to sinus rhythm was consistently achieved. A favourable response occurred in four patients in whom arrhythmias were associated with pre-excitation syndromes. There were no adverse clinical side effects.
No takes yet. Share an insight, caveat, or question.
Schamroth et al. (1972) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: